5-year survival outcomes in patients (pts) with advanced melanoma treated with pembrolizumab (pembro) in KEYNOTE-001 Meeting Abstract
| Authors: | Hamid, O.; Robert, C.; Daud, A.; Hodi, F. S.; Hwu, W. J.; Kefford, R.; Wolchok, J. D.; Hersey, P.; Joseph, R. W.; Weber, J. S.; Dronca, R. S.; Mitchell, T. C.; Patnaik, A.; Zarour, H. M.; Joshua, A. M.; Jensen, E.; Ibrahim, N.; Ahsan, S.; Ribas, A. |
| Abstract Title: | 5-year survival outcomes in patients (pts) with advanced melanoma treated with pembrolizumab (pembro) in KEYNOTE-001 |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 494s |
| Language: | English |
| ACCESSION: | WOS:000442916003293 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9516 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9516 -- Source: Wos |
